Comparison Matrix-Associated Stem Cell Transplantation (MAST) with Autologous Matrix Induced Chondrogenesis plus Peripheral Blood Concentrate (AMIC+PBC) in Chondral Lesions at the Ankle - Matched-Patient Analysis
Category: Ankle Introduction/Purpose: 2016, the local government authorities re-categorized MAST, i.e. the included BMAC for impregnation of the matrix, as stem call manufacturing and heterologous transplantation. Consequently, MAST and all other procedures including BMAC were not ‘subject to disclo...
Main Authors: | Martinus Richter MD, PhD, Stefan Zech MD, Stefan A. Meissner, Issam Naef |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Foot & Ankle Orthopaedics |
Online Access: | https://doi.org/10.1177/2473011420S00402 |
Similar Items
-
Autologous Matrix Induced Chondrogenesis plus Peripheral Blood Concentrate (AMIC+PBC) in Chondral Lesions at the Ankle as Part of a Complex Surgical Approach: 5-Year Follow-up
by: Martinus Richter MD, PhD, et al.
Published: (2023-12-01) -
Autologous Matrix Induced Chondrogenesis plus Peripheral Blood Concentrate (AMIC+PBC) in Chondral Defects of the First Metatarsophalangeal Joint: 5-Year Follow-up
by: Martinus Richter MD, PhD, et al.
Published: (2023-12-01) -
Matrix-Associated Stem Cell Transplantation (MAST) in Chondral Defects of the Ankle is Safe and Effective - 5-Year-Followup
by: Martinus Richter MD, PhD, et al.
Published: (2017-09-01) -
Mid-term (4-7 years) Results of Matrix-Associated Stem Cell Transplantation (MAST) in Chondral Defects of the First Metatarsophalangeal Joint
by: Martinus Richter MD, PhD, et al.
Published: (2019-10-01) -
Matrix-Associated Stem Cell Transplantation (MAST) in Chondral Defects of the Ankle is Safe and Effective - 2-Year-Followup in 130 Patients
by: Martinus Richter MD, PhD, et al.
Published: (2016-08-01)